Announcement

Collapse
No announcement yet.

Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection

    Sci Rep. 2017 Dec 12;7(1):17360. doi: 10.1038/s41598-017-17487-8.
    Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection.

    Jung YJ1, Lee YT1, Ngo VL1, Cho YH2, Ko EJ1, Hong SM2, Kim KH1, Jang JH3, Oh JS3, Park MK4, Kim CH2, Sun J5, Kang SM6.
    Author information

    Abstract

    Lactic acid bacteria (LAB) are the common probiotics. Here, we investigated the antiviral protective effects of heat-killed LAB strain Lactobacillus casei DK128 (DK128) on influenza viruses. Intranasal treatment of mice with DK128 conferred protection against different subtypes of influenza viruses by lessening weight loss and lowering viral loads. Protection via heat-killed DK128 was correlated with an increase in alveolar macrophage cells in the lungs and airways, early induction of virus specific antibodies, reduced levels of pro-inflammatory cytokines and innate immune cells. Importantly, the mice that were protected against primary viral infection as a result of heat-killed DK128 pretreatment developed subsequent heterosubtypic immunity against secondary virus infection. For protection against influenza virus via heat-killed DK128 pretreatment, B cells and partially CD4 T cells but not CD8 T cells were required as inferred from studies using knockout mouse models. Our study provides insight into how hosts can be equipped with innate and adaptive immunity via heat-killed DK128 treatment to protect against influenza virus, supporting that heat-killed LAB may be developed as anti-virus probiotics.


    PMID: 29234060 DOI: 10.1038/s41598-017-17487-8
    Free PMC Article
Working...
X